Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH
dc.contributor.author | Barnes, G. D. | en_US |
dc.contributor.author | Ageno, W. | en_US |
dc.contributor.author | Ansell, J. | en_US |
dc.contributor.author | Kaatz, S. | en_US |
dc.date.accessioned | 2015-07-01T20:56:06Z | |
dc.date.available | 2016-07-05T17:27:58Z | en |
dc.date.issued | 2015-06 | en_US |
dc.identifier.citation | Barnes, G. D.; Ageno, W.; Ansell, J.; Kaatz, S. (2015). "Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH." Journal of Thrombosis and Haemostasis 13(6): 1154-1156. | en_US |
dc.identifier.issn | 1538-7933 | en_US |
dc.identifier.issn | 1538-7836 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/111930 | |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.title | Recommendation on the nomenclature for oral anticoagulants: communication from the SSC of the ISTH | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/111930/1/jth12969.pdf | |
dc.identifier.doi | 10.1111/jth.12969 | en_US |
dc.identifier.source | Journal of Thrombosis and Haemostasis | en_US |
dc.identifier.citedreference | Baglin T, Hillarp A, Tripodi A, Elalamy I, Buller H, Ageno W. Measuring oral direct inhibitors (ODIs) of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2013; 11: 756 – 60. | en_US |
dc.identifier.citedreference | Lip GY, Camm AJ, Hylek EM, Halperin JL, Weitz JI. Non‐vitamin K antagonist oral anticoagulants: an appeal for consensus on terminology. Chest 2014; 145: 1177 – 8. | en_US |
dc.identifier.citedreference | Institute for Safe Medication Practices. Medication Safety Alert. Volume 18, Issue 25. 12 December 2013. | en_US |
dc.identifier.citedreference | Husted S, Lip GY, ESC Working Group on Thrombosis Task Force on Antocoagulants in Heart Disease. Response to Ansell et al. Non‐vitamin K antagonist oral anticoagulants (NOACs): no longer new or novel. (Thromb Haemost 2014; 112: 841). Thromb Haemost 2014; 112: 842. | en_US |
dc.identifier.citedreference | Husted S, de Caterina R, Andreotti F, Arnesen H, Bachmann F, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Siegbahn A, Storey RF, Weitz JI, ESC Working Group on Thrombosis Task Force on Antocoagulants in Heart Disease. Non‐vitamin K antagonist oral anticoagulants (NOACs): no longer new or novel. Thromb Haemost 2014; 111: 781 – 2. | en_US |
dc.identifier.citedreference | Asmis LM. Direct oral anticoagulants (DOACs) versus ‘new’ oral anticoagulants (NOACs)? Semin Hematol 2014; 51: 87 – 8. | en_US |
dc.identifier.citedreference | Ansell J, Crowther M, Burnett A, Garcia D, Kaatz S, Lopes RD, Nutescu E, Oertel L, Schnurr T, Streiff M, Wirth D, Witt D, Wittkowsky A, Anticoagulation Forum. Comment on: editorial by Husted et al. ‘Non‐vitamin K antagonist oral anticoagulants (NOACs): no longer new or novel’. (Thromb Haemost 2014; 111: 781‐782). Thromb Haemost 2014; 112: 841. | en_US |
dc.identifier.citedreference | ISMP's List of Error‐Prone Abbreviations, Symbols, and Dose Designations, Institute for Safe Medication Practice; 2013. Available from: http://www.ismp.org/tools/errorproneabbreviations.pdf | en_US |
dc.identifier.citedreference | Verhamme P, Bounameaux H. Direct oral anticoagulants for acute venous thromboembolism: closing the circle? Circulation 2014; 129: 725 – 7. | en_US |
dc.identifier.citedreference | Hohnloser SH. Apixaban: a new direct oral anticoagulant for stroke prevention in atrial fibrillation. Eur Heart J 2014; 35: 1828 – 9. | en_US |
dc.identifier.citedreference | van Es N, Coppens M, Schulman S, Middeldorp S, Buller HR. Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. Blood 2014; 124: 1968 – 75. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.